Correlation Between Effector Therapeutics and Absci Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Absci Corp, you can compare the effects of market volatilities on Effector Therapeutics and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Absci Corp.

Diversification Opportunities for Effector Therapeutics and Absci Corp

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Effector and Absci is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Absci Corp go up and down completely randomly.

Pair Corralation between Effector Therapeutics and Absci Corp

If you would invest  13.00  in Effector Therapeutics on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Effector Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.35%
ValuesDaily Returns

Effector Therapeutics  vs.  Absci Corp

 Performance 
       Timeline  
Effector Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Effector Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Absci Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Absci Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Effector Therapeutics and Absci Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Effector Therapeutics and Absci Corp

The main advantage of trading using opposite Effector Therapeutics and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.
The idea behind Effector Therapeutics and Absci Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios